CX Institutional’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.4M | Sell |
100,656
-792
| -0.8% | -$70.7K | 0.3% | 74 |
|
|
2026
Q1 | $7.29M | Sell |
101,448
-16,874
| -14% | -$1.3M | 0.22% | 109 |
|
|
2025
Q4 | $9.39M | Buy |
118,322
+1,361
| +1% | +$107K | 0.28% | 88 |
|
|
2025
Q3 | $8.82M | Buy |
116,961
+8,114
| +7% | +$556K | 0.27% | 87 |
|
|
2025
Q2 | $7.51M | Buy |
108,847
+77,685
| +249% | +$5.09M | 0.26% | 79 |
|
|
2025
Q1 | $2.11M | Sell |
31,162
-69,625
| -69% | -$4.17M | 0.08% | 192 |
|
|
2024
Q4 | $4.52M | Buy |
100,787
+26,178
| +35% | +$1.47M | 0.18% | 137 |
|
|
2024
Q3 | $4.69M | Buy |
74,609
+65,259
| +698% | +$3.81M | 0.21% | 135 |
|
|
2024
Q2 | $552K | Buy |
9,350
+2,589
| +38% | +$162K | 0.03% | 355 |
|
|
2024
Q1 | $539K | Buy |
6,761
+429
| +7% | +$32.8K | 0.03% | 359 |
|
|
2023
Q4 | $500K | Buy |
6,332
+2,068
| +48% | +$147K | 0.03% | 330 |
|
|
2023
Q3 | $298K | Sell |
4,264
-3,449
| -45% | -$244K | 0.02% | 402 |
|
|
2023
Q2 | $533K | Buy |
+7,713
| New | +$549K | 0.03% | 339 |
|
|
2023
Q1 | – | Sell |
-33,527
| Closed | -$3.12M | – | 495 |
|
|
2022
Q4 | $3.12M | Sell |
33,527
-1,939
| -5% | -$187K | 0.19% | 152 |
|
|
2022
Q3 | $3.38M | Buy |
35,466
+10,883
| +44% | +$1.08M | 0.23% | 104 |
|
|
2022
Q2 | $2.28M | Sell |
24,583
-1,649
| -6% | -$161K | 0.17% | 148 |
|
|
2022
Q1 | $2.65M | Buy |
26,232
+22,958
| +701% | +$2.41M | 0.21% | 126 |
|
|
2021
Q4 | $338K | Buy |
3,274
+248
| +8% | +$22.9K | 0.03% | 276 |
|
|
2021
Q3 | $257K | Buy |
3,026
+343
| +13% | +$28.7K | 0.02% | 331 |
|
|
2021
Q2 | $224K | Buy |
2,683
+491
| +22% | +$40.2K | 0.02% | 328 |
|
|
2021
Q1 | $165K | Buy |
2,192
+414
| +23% | +$30.2K | 0.01% | 325 |
|
|
2020
Q4 | $122K | Buy |
1,778
+599
| +51% | +$39K | 0.01% | 333 |
|
|
2020
Q3 | $69K | Sell |
1,179
-484
| -29% | -$30.1K | 0.01% | 351 |
|
|
2020
Q2 | $108K | Sell |
1,663
-293
| -15% | -$18.5K | 0.01% | 282 |
|
|
2020
Q1 | $116K | Sell |
1,956
-55,472
| -97% | -$3.7M | 0.02% | 257 |
|
|
2019
Q4 | $4.27M | Sell |
57,428
-2,549
| -4% | -$179K | 0.74% | 35 |
|
|
2019
Q3 | $3.78M | Buy |
59,977
+33,088
| +123% | +$1.96M | 0.61% | 41 |
|
|
2019
Q2 | $1.47M | Sell |
26,889
-61,481
| -70% | -$3.31M | 0.23% | 98 |
|
|
2019
Q1 | $4.77M | Sell |
88,370
-1,396
| -2% | -$86.2K | 0.84% | 35 |
|
|
2018
Q4 | $5.88M | Buy |
89,766
+31,365
| +54% | +$2.34M | 1.24% | 29 |
|
|
2018
Q3 | $4.6M | Buy |
58,401
+3,008
| +5% | +$215K | 1.52% | 23 |
|
|
2018
Q2 | $3.56M | Buy |
+55,393
| New | +$3.65M | 1.32% | 29 |
|
Other funds holding CVS
CX Institutional's CVS Position: Q2 2026 in Review
CX Institutional reduced its CVS Health (CVS) stake by 0.78% in Q2 2026, selling an estimated $70.7K and leaving 100,656 shares worth $10.4M. The position accounts for 0.3% of the portfolio, ranked #74.
CX Institutional first reported a position in CVS in Q2 2018 and has held it in 32 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- CX Institutional held 100,656 shares of CVS Health worth $10.4M as of Q2 2026.
- CX Institutional sold 792 CVS Health shares in Q2 2026, an estimated $70.7K.
- CVS Health made up 0.3% of CX Institutional's portfolio in Q2 2026, its #74 holding.
- CX Institutional first reported a position in CVS Health in Q2 2018 and has held it in 32 quarters since.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.